- Connectivity Mapping Using a Novel sv2a Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery(2022)
Auteurs: Lise Heylen, Michèle Partoens, Peter de Witte, Aleksandra Siekierska
- From the North Sea to Drug Repurposing, the Antiseizure Activity of Halimide and Plinabulin.(2022)
Auteurs: Daniëlle Copmans, Emma Roux, Michèle Partoens, Gert Steurs, Wim De Borggraeve, Peter de Witte
- Modeling Neurodevelopmental Disorders and Epilepsy Caused by Loss of Function of kif2a in Zebrafish(2021)
Auteurs: Michèle Partoens, Ann-Sofie De Meulemeester, Peter de Witte, Aleksandra Siekierska
- Zebrafish-Based Screening of Antiseizure Plants Used in Traditional Chinese Medicine: Magnolia officinalis Extract and Its Constituents Magnolol and Honokiol Exhibit Potent Anticonvulsant Activity in a Therapy-Resistant Epilepsy Model(2020)
Auteurs: jing Li, Daniëlle Copmans, Michèle Partoens, Walter Luyten, Peter de Witte
Pagina's: 730 - 742
- Zebrafish-Based Discovery of Antiseizure Compounds from the North Sea: Isoquinoline Alkaloids TMC-120A and TMC-120B(2019)
Auteurs: Daniëlle Copmans, Michèle Partoens, Camila Esguerra, Peter de Witte
- Biallelic VARS variants cause developmental encephalopathy with microcephaly that is recapitulated in vars knockout zebrafish(2019)
Auteurs: Aleksandra Siekierska, Michèle Partoens, Jo Sourbron, Peter de Witte
- Drug repurposing for Dravet syndrome in scn1Lab-/- mutant zebrafish(2019)
Auteurs: Jo Sourbron, Michèle Partoens, Chloë Scheldeman, Lieven Lagae, Peter de Witte
Pagina's: E8 - E13